Cargando…

Ultrahigh dose rate pencil beam scanning proton dosimetry using ion chambers and a calorimeter in support of first in‐human FLASH clinical trial

PURPOSE: To provide ultrahigh dose rate (UHDR) pencil beam scanning (PBS) proton dosimetry comparison of clinically used plane‐parallel ion chambers, PTW (Physikalisch‐Technische Werkstaetten) Advanced Markus and IBA (Ion Beam Application) PPC05, with a proton graphite calorimeter in a support of fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eunsin, Lourenço, Ana Mónica, Speth, Joseph, Lee, Nigel, Subiel, Anna, Romano, Francesco, Thomas, Russell, Amos, Richard A., Zhang, Yongbin, Xiao, Zhiyan, Mascia, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546035/
https://www.ncbi.nlm.nih.gov/pubmed/35780318
http://dx.doi.org/10.1002/mp.15844
_version_ 1784804952443453440
author Lee, Eunsin
Lourenço, Ana Mónica
Speth, Joseph
Lee, Nigel
Subiel, Anna
Romano, Francesco
Thomas, Russell
Amos, Richard A.
Zhang, Yongbin
Xiao, Zhiyan
Mascia, Anthony
author_facet Lee, Eunsin
Lourenço, Ana Mónica
Speth, Joseph
Lee, Nigel
Subiel, Anna
Romano, Francesco
Thomas, Russell
Amos, Richard A.
Zhang, Yongbin
Xiao, Zhiyan
Mascia, Anthony
author_sort Lee, Eunsin
collection PubMed
description PURPOSE: To provide ultrahigh dose rate (UHDR) pencil beam scanning (PBS) proton dosimetry comparison of clinically used plane‐parallel ion chambers, PTW (Physikalisch‐Technische Werkstaetten) Advanced Markus and IBA (Ion Beam Application) PPC05, with a proton graphite calorimeter in a support of first in‐human proton FLASH clinical trial. METHODS: Absolute dose measurement intercomparison of the plane‐parallel plate ion chambers and the proton graphite calorimeter was performed at 5‐cm water‐equivalent depth using rectangular 250‐MeV single‐layer treatment plans designed for the first in‐human FLASH clinical trial. The dose rate for each field was designed to remain above 60 Gy/s. The ion recombination effects of the plane‐parallel plate ion chambers at various bias voltages were also investigated in the range of dose rates between 5 and 60 Gy/s. Two independent model‐based extrapolation methods were used to calculate the ion recombination correction factors k(s) to compare with the two‐voltage technique from most widely used clinical protocols. RESULTS: The mean measured dose to water with the proton graphite calorimeter across all the predefined fields is 7.702 ± 0.037 Gy. The average ratio over the predefined fields of the PTW Advanced Markus chamber dose to the calorimeter reference dose is 1.002 ± 0.007, whereas the IBA PPC05 chamber shows ∼3% higher reading of 1.033 ± 0.007. The relative differences in the k(s) values determined from between the linear and quadratic extrapolation methods and the two‐voltage technique for the PTW Advanced Markus chamber are not statistically significant, and the trends of dose rate dependence are similar. The IBA PPC05 shows a flat response in terms of ion recombination effects based on the k(s) values calculated using the two‐voltage technique. Differences in k(s) values for the PPC05 between the two‐voltage technique and other model‐based extrapolation methods are not statistically significant at FLASH dose rates. Some of the k(s) values for the PPC05 that were extrapolated from the three‐voltage linear method and the semiempirical model were reported less than unity possibly due to the charge multiplication effect, which was negligible compared to the volume recombination effect in FLASH dose rates. CONCLUSIONS: The absolute dose measurements of both PTW Advanced Markus and IBA PPC05 chambers are in a good agreement with the National Physical Laboratory graphite calorimeter reference dose considering overall uncertainties. Both ion chambers also demonstrate good reproducibility as well as stability as reference dosimeters in UHDR PBS proton radiotherapy. The dose rate dependency of the ion recombination effects of both ion chambers in cyclotron generated PBS proton beams is acceptable and therefore, both chambers are suitable to use in clinical practice for the range of dose rates between 5 and 60 Gy/s.
format Online
Article
Text
id pubmed-9546035
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95460352022-10-14 Ultrahigh dose rate pencil beam scanning proton dosimetry using ion chambers and a calorimeter in support of first in‐human FLASH clinical trial Lee, Eunsin Lourenço, Ana Mónica Speth, Joseph Lee, Nigel Subiel, Anna Romano, Francesco Thomas, Russell Amos, Richard A. Zhang, Yongbin Xiao, Zhiyan Mascia, Anthony Med Phys COMPUTATIONAL AND EXPERIMENTAL DOSIMETRY PURPOSE: To provide ultrahigh dose rate (UHDR) pencil beam scanning (PBS) proton dosimetry comparison of clinically used plane‐parallel ion chambers, PTW (Physikalisch‐Technische Werkstaetten) Advanced Markus and IBA (Ion Beam Application) PPC05, with a proton graphite calorimeter in a support of first in‐human proton FLASH clinical trial. METHODS: Absolute dose measurement intercomparison of the plane‐parallel plate ion chambers and the proton graphite calorimeter was performed at 5‐cm water‐equivalent depth using rectangular 250‐MeV single‐layer treatment plans designed for the first in‐human FLASH clinical trial. The dose rate for each field was designed to remain above 60 Gy/s. The ion recombination effects of the plane‐parallel plate ion chambers at various bias voltages were also investigated in the range of dose rates between 5 and 60 Gy/s. Two independent model‐based extrapolation methods were used to calculate the ion recombination correction factors k(s) to compare with the two‐voltage technique from most widely used clinical protocols. RESULTS: The mean measured dose to water with the proton graphite calorimeter across all the predefined fields is 7.702 ± 0.037 Gy. The average ratio over the predefined fields of the PTW Advanced Markus chamber dose to the calorimeter reference dose is 1.002 ± 0.007, whereas the IBA PPC05 chamber shows ∼3% higher reading of 1.033 ± 0.007. The relative differences in the k(s) values determined from between the linear and quadratic extrapolation methods and the two‐voltage technique for the PTW Advanced Markus chamber are not statistically significant, and the trends of dose rate dependence are similar. The IBA PPC05 shows a flat response in terms of ion recombination effects based on the k(s) values calculated using the two‐voltage technique. Differences in k(s) values for the PPC05 between the two‐voltage technique and other model‐based extrapolation methods are not statistically significant at FLASH dose rates. Some of the k(s) values for the PPC05 that were extrapolated from the three‐voltage linear method and the semiempirical model were reported less than unity possibly due to the charge multiplication effect, which was negligible compared to the volume recombination effect in FLASH dose rates. CONCLUSIONS: The absolute dose measurements of both PTW Advanced Markus and IBA PPC05 chambers are in a good agreement with the National Physical Laboratory graphite calorimeter reference dose considering overall uncertainties. Both ion chambers also demonstrate good reproducibility as well as stability as reference dosimeters in UHDR PBS proton radiotherapy. The dose rate dependency of the ion recombination effects of both ion chambers in cyclotron generated PBS proton beams is acceptable and therefore, both chambers are suitable to use in clinical practice for the range of dose rates between 5 and 60 Gy/s. John Wiley and Sons Inc. 2022-07-14 2022-09 /pmc/articles/PMC9546035/ /pubmed/35780318 http://dx.doi.org/10.1002/mp.15844 Text en © 2022 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle COMPUTATIONAL AND EXPERIMENTAL DOSIMETRY
Lee, Eunsin
Lourenço, Ana Mónica
Speth, Joseph
Lee, Nigel
Subiel, Anna
Romano, Francesco
Thomas, Russell
Amos, Richard A.
Zhang, Yongbin
Xiao, Zhiyan
Mascia, Anthony
Ultrahigh dose rate pencil beam scanning proton dosimetry using ion chambers and a calorimeter in support of first in‐human FLASH clinical trial
title Ultrahigh dose rate pencil beam scanning proton dosimetry using ion chambers and a calorimeter in support of first in‐human FLASH clinical trial
title_full Ultrahigh dose rate pencil beam scanning proton dosimetry using ion chambers and a calorimeter in support of first in‐human FLASH clinical trial
title_fullStr Ultrahigh dose rate pencil beam scanning proton dosimetry using ion chambers and a calorimeter in support of first in‐human FLASH clinical trial
title_full_unstemmed Ultrahigh dose rate pencil beam scanning proton dosimetry using ion chambers and a calorimeter in support of first in‐human FLASH clinical trial
title_short Ultrahigh dose rate pencil beam scanning proton dosimetry using ion chambers and a calorimeter in support of first in‐human FLASH clinical trial
title_sort ultrahigh dose rate pencil beam scanning proton dosimetry using ion chambers and a calorimeter in support of first in‐human flash clinical trial
topic COMPUTATIONAL AND EXPERIMENTAL DOSIMETRY
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546035/
https://www.ncbi.nlm.nih.gov/pubmed/35780318
http://dx.doi.org/10.1002/mp.15844
work_keys_str_mv AT leeeunsin ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT lourencoanamonica ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT spethjoseph ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT leenigel ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT subielanna ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT romanofrancesco ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT thomasrussell ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT amosricharda ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT zhangyongbin ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT xiaozhiyan ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial
AT masciaanthony ultrahighdoseratepencilbeamscanningprotondosimetryusingionchambersandacalorimeterinsupportoffirstinhumanflashclinicaltrial